Dr. Reddy's Laboratories Advances Friday, Outperforms Competitors

Dow Jones06-05

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Dr. Reddy's Laboratories Ltd. inched up 0.85% to 1,277.80 Indian rupees Friday, on what proved to be an all-around rough trading session for the stock market, with the BSE SENSEX Index falling 0.16% to 74,243.34.

Dr. Reddy's Laboratories Ltd. closed 7.27% below its 52-week high of 1,377.95 rupees, which the company reached on June 12th.

The stock outperformed some of its competitors Friday, as Lupin Ltd. rose 0.80% and Zydus Lifesciences Ltd. rose 0.41%. Wockhardt Ltd. fell 7.33%.

Trading volume totaled 17,118, compared to the 50-day average of 97,299.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

June 05, 2026 06:31 ET (10:31 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2641114797?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-05 18:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2641114797","market":"other","top_or_hot":-1,"title":"Dr. Reddy's Laboratories Advances Friday, Outperforms Competitors","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     Shares of Dr. Reddy's Laboratories Ltd.  inched up 0.85% to 1,277.80 Indian rupees Friday, on what proved to be an all-around rough trading session for the stock market, with the BSE SENSEX Index  falling 0.16% to 74,243.34. \n</p>\n<p>\n     Dr. Reddy's Laboratories Ltd. closed 7.27% below its 52-week high of 1,377.95 rupees, which the company reached on June 12th. \n</p>\n<p>\n     The stock outperformed some of its competitors Friday, as Lupin Ltd.  rose 0.80% and Zydus Lifesciences Ltd.  rose 0.41%. Wockhardt Ltd.  fell 7.33%. \n</p>\n<p>\n     Trading volume totaled 17,118, compared to the 50-day average of 97,299. \n</p>\n<p>\n  Data source: Dow Jones Market Data, FactSet \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  June 05, 2026 06:31 ET (10:31 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dr. Reddy's Laboratories Advances Friday, Outperforms Competitors</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDr. Reddy's Laboratories Advances Friday, Outperforms Competitors\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-06-05 18:31</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     Shares of Dr. Reddy's Laboratories Ltd.  inched up 0.85% to 1,277.80 Indian rupees Friday, on what proved to be an all-around rough trading session for the stock market, with the BSE SENSEX Index  falling 0.16% to 74,243.34. \n</p>\n<p>\n     Dr. Reddy's Laboratories Ltd. closed 7.27% below its 52-week high of 1,377.95 rupees, which the company reached on June 12th. \n</p>\n<p>\n     The stock outperformed some of its competitors Friday, as Lupin Ltd.  rose 0.80% and Zydus Lifesciences Ltd.  rose 0.41%. Wockhardt Ltd.  fell 7.33%. \n</p>\n<p>\n     Trading volume totaled 17,118, compared to the 50-day average of 97,299. \n</p>\n<p>\n  Data source: Dow Jones Market Data, FactSet \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  June 05, 2026 06:31 ET (10:31 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4523","symbol_name":"印度概念","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2641114797","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2641114797","pubTimestamp":1780655460,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Dr. Reddy's Laboratories Ltd.  inched up 0.85% to 1,277.80 Indian rupees Friday, on what proved to be an all-around rough trading session for the stock market, with the BSE SENSEX Index  falling 0.16% to 74,243.34.Dr. Reddy's Laboratories Ltd. closed 7.27% below its 52-week high of 1,377.95 rupees, which the company reached on June 12th.The stock outperformed some of its competitors Friday, as Lupin Ltd.  rose 0.80% and Zydus Lifesciences Ltd.  rose 0.41%. Wockhardt Ltd.  fell 7.33%.Trading volume totaled 17,118, compared to the 50-day average of 97,299.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4523":"印度概念","RDY":"如瑞迪博士","LU0348744763.USD":"ALLIANZ ASIA PACIFIC INCOME \"A\" (USD) INC","BK4557":"大麻股","BK4532":"文艺复兴科技持仓","BK4596":"哈里斯概念","BK4007":"制药"},"translate_title":"雷迪博士实验室周五取得进展，表现优于竞争对手","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RDY":0.9},"content_text":"This article was automatically generated by MarketWatch using technology from Automated Insights. \n\n\n     Shares of Dr. Reddy's Laboratories Ltd.  inched up 0.85% to 1,277.80 Indian rupees Friday, on what proved to be an all-around rough trading session for the stock market, with the BSE SENSEX Index  falling 0.16% to 74,243.34. \n\n\n     Dr. Reddy's Laboratories Ltd. closed 7.27% below its 52-week high of 1,377.95 rupees, which the company reached on June 12th. \n\n\n     The stock outperformed some of its competitors Friday, as Lupin Ltd.  rose 0.80% and Zydus Lifesciences Ltd.  rose 0.41%. Wockhardt Ltd.  fell 7.33%. \n\n\n     Trading volume totaled 17,118, compared to the 50-day average of 97,299. \n\n\n  Data source: Dow Jones Market Data, FactSet \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 05, 2026 06:31 ET (10:31 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2641114797","isCrawlerRequest":true}